Health Canada approves isoquercetin COVID-19 trial - ICAV network 2nd trial - ICAV

Health Canada approves isoquercetin COVID-19 trial – ICAV network 2nd trial

Read more

Jeremy Carver PhD | President and CEO

© ICAV 2020.

Created by MtoM Création

logo-the-international-consortium-on-anti-virals-icav-canada

Contact